Hedge Fund - Camber Capital Management
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $9.34 |
| 2 | 2023 - Q3 (2023-09-30) | $103,530,000 | 3.41% | 10,150,000 | $9.31 |
| 3 | 2023 - Q2 (2023-06-30) | $64,005,000 | 2.08% | 8,500,000 | $8.11 |
| 4 | 2023 - Q1 (2023-03-31) | $26,550,000 | 0.81% | 3,000,000 | $9.89 |
| 5 | 2022 - Q4 (2022-12-31) | $63,840,000 | 2.18% | 7,000,000 | $8.73 |
| 6 | 2022 - Q3 (2022-09-30) | $60,525,000 | 1.85% | 7,500,000 | $8.84 |
| 7 | 2022 - Q2 (2022-06-30) | $20,680,000 | 0.89% | 2,750,000 | $8.71 |
| 8 | 2022 - Q1 (2022-03-31) | $25,823,000 | 0.93% | 2,750,000 | $8.35 |
| 9 | 2021 - Q4 (2021-12-31) | $22,028,000 | 0.75% | 2,750,000 | $9.03 |
| 10 | 2021 - Q3 (2021-09-30) | $48,700,000 | 1.49% | 5,000,000 | $9.36 |
| 11 | 2021 - Q2 (2021-06-30) | $54,450,000 | 1.83% | 5,500,000 | $10.58 |
| 12 | 2021 - Q1 (2021-03-31) | $63,470,000 | 2.17% | 5,500,000 | $11.47 |
| 13 | 2020 - Q4 (2020-12-31) | $43,425,000 | 1.52% | 4,500,000 | $9.58 |
| 14 | 2020 - Q3 (2020-09-30) | $40,545,000 | 2.13% | 4,500,000 | $10.58 |
| 15 | 2020 - Q2 (2020-06-30) | $24,660,000 | 1.41% | 2,000,000 | $11.31 |
| 16 | 2020 - Q1 (2020-03-31) | $0 | 0% | 0 | $10.25 |
| 17 | 2019 - Q4 (2019-12-31) | $19,600,000 | 0.99% | 2,000,000 | $8.93 |
| 18 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $7.66 |
| 19 | 2019 - Q2 (2019-06-30) | $59,995,000 | 2.79% | 6,500,000 | $12.06 |
| 20 | 2019 - Q1 (2019-03-31) | $54,880,000 | 2.73% | 3,500,000 | $17.63 |
| 21 | 2017 - Q3 (2017-09-30) | $0 | 0% | 0 | $22.50 |
| 22 | 2017 - Q2 (2017-06-30) | $174,951,000 | 8.51% | 5,266,450 | $30.95 |
| 23 | 2017 - Q1 (2017-03-31) | $167,396,000 | 6.78% | 5,216,450 | $34.13 |
| 24 | 2016 - Q4 (2016-12-31) | $171,261,000 | 8.91% | 4,724,450 | $39.93 |
| 25 | 2016 - Q3 (2016-09-30) | $184,040,000 | 8.09% | 4,000,000 | $52.17 |
| 26 | 2016 - Q2 (2016-06-30) | $144,160,000 | 6.96% | 2,870,000 | $53.24 |
| 27 | 2016 - Q1 (2016-03-31) | $120,398,000 | 7.05% | 2,250,000 | $58.67 |
| 28 | 2015 - Q4 (2015-12-31) | $118,152,000 | 7.63% | 1,800,000 | $61.80 |
| 29 | 2015 - Q3 (2015-09-30) | $112,920,000 | 9.67% | 2,000,000 | $64.84 |
| 30 | 2015 - Q2 (2015-06-30) | $103,425,000 | 7.04% | 1,750,000 | $61.69 |
| 31 | 2015 - Q1 (2015-03-31) | $102,795,000 | 7.33% | 1,650,000 | $58.14 |
| 32 | 2014 - Q4 (2014-12-31) | $100,643,000 | 6.72% | 1,750,000 | $55.71 |
| 33 | 2014 - Q3 (2014-09-30) | $94,062,000 | 8.83% | 1,750,000 | $52.98 |
| 34 | 2014 - Q2 (2014-06-30) | $91,735,000 | 6.01% | 1,750,000 | $51.11 |
| 35 | 2014 - Q1 (2014-03-31) | $87,186,000 | 6.83% | 1,650,000 | $46.22 |
| 36 | 2013 - Q4 (2013-12-31) | $80,160,000 | 7.07% | 2,000,000 | $39.38 |
| 37 | 2013 - Q3 (2013-09-30) | $75,560,000 | 7.92% | 2,000,000 | $39.01 |
| 38 | 2013 - Q2 (2013-06-30) | $29,400,000 | 3.01% | 750,000 | $38.94 |
| 39 | 2013 - Q1 (2013-03-31) | $59,520,000 | 4.87% | 1,500,000 | $38.59 |
| 40 | 2012 - Q4 (2012-12-31) | $37,340,000 | 4.67% | 1,000,000 | $39.91 |
The displayed share prices are average quarterly stock market prices.